A Prospective Study of a New Device for Monitoring Cerebral Oxygenation on Healthy Volunteers
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00598819 |
Recruitment Status
:
Completed
First Posted
: January 23, 2008
Results First Posted
: July 7, 2010
Last Update Posted
: August 17, 2011
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Cerebral Ischemia | Device: CDI 1000 COM | Phase 1 |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 14 participants |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Diagnostic |
Official Title: | A Prospective Study With a New Device for the Monitoring of Cerebral Oxygenation on Healthy Volunteers |
Study Start Date : | October 2007 |
Actual Primary Completion Date : | May 2009 |
Actual Study Completion Date : | May 2009 |
Arm | Intervention/treatment |
---|---|
Experimental: Healthy Volunteers
Healthy subjects testing the device.
|
Device: CDI 1000 COM
CDI 1000 COM sensors were attached to subject's forehead for a 12 hour period.
Other Name: Terumo CDI 1000 COM
|
- Harm to Skin From Attachment of Sensor to Forehead: Cuts, Bruising, Rash or Allergic Reactions to Adhesive. [ Time Frame: attachment of sensor to 24 hours post-removal ]Measurement of reactions to the sensor's attachment to the skin on the forehead. Measurement of the outcome is either reaction or no reaction. This means that all subjects are either measured as having a reaction at all or having no reaction at all. Measurement and reactions assessment performed by the investigator.
- Overheating of Skin Underneath Sensor. [ Time Frame: placement of sensor to 10 minutes post-removal. ]
The Principal measure for this outcome was discomfort and potential harm from overheating while attached to an active study participant. The investigator of the study asked to the participant if he/she felt:
• Discomfort in the sensor application zone; Itching, Burning sensation and/or Pain. The skin was examined before and after the sensor application. All the assessments were performed by the principal investigator of the study.
- Overheating of Skin Underneath Sensor [ Time Frame: placement of sensor to immediately post-removal ]
The Principal measure for this outcome was discomfort and potential harm from overheating while attached to an active study participant. The investigator of the study asked to the participant if he/she felt:
• Discomfort in the sensor application zone; Itching, Burning sensation and/or Pain. The skin was examined before and after the sensor application. All the assessments were performed by the principal investigator of the study.
- Sensor Fits Well on Subjects Forehead [ Time Frame: placement of sensor to end of study observation ]How well the sensor seems to fit on the subject's forehead in terms of curvature, comfort and adherence. The fitting assessment was assessed visually and determined based in the size of the sensor and the length of forehead covered, also the adhesion test was performed by hanging weight of 2 LBS on the sensor for 10 min, recording if the sensor kept attached to the skin or not. All tests and measures were assessed by the investigator. All the characteristics of the sensor (curvature, comfort and adherence) were recorded on each subjects as "yes" or "no".
- Sensor Attachment Under Stress [ Time Frame: addition of stress on sensor to removal. ]
The Principal measure for this outcome was discomfort and potential harm from overheating while attached to an active study participant. The investigator of the study asked to the participant if he/she felt:
• Discomfort in the sensor application zone; Itching, Burning sensation and/or Pain. The skin was examined before and after the sensor application. All the assessments were performed by the principal investigator of the study.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
INCLUSION CRITERIA:
- Healthy male or Female Volunteers
- 18 years old or older
- Capable and willing to operate a bicycle
- Understand enough about the risks and benefits of the study to be able to make an informed decision before agreeing to be in the study
EXLUSION CRITERIA:
- History of Cerebrovascular Disease
- History of Skin Problems on Forehead (Skin Rashes, Acne, Allergies, etc.)
- Pregnancy

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00598819
United States, California | |
University of California, Irvine Medical Center | |
Orange, California, United States, 92868 |
Principal Investigator: | Jeffrey C Milliken, MD | University of California, Irvine |
Responsible Party: | Jeffrey Milliken, MD, University of California, Irvine |
ClinicalTrials.gov Identifier: | NCT00598819 History of Changes |
Other Study ID Numbers: |
2007-5593 |
First Posted: | January 23, 2008 Key Record Dates |
Results First Posted: | July 7, 2010 |
Last Update Posted: | August 17, 2011 |
Last Verified: | August 2011 |
Keywords provided by University of California, Irvine:
Cerebral Oxygenation Oxygen Monitoring |
Additional relevant MeSH terms:
Ischemia Brain Ischemia Cerebral Infarction Pathologic Processes Cerebrovascular Disorders Brain Diseases |
Central Nervous System Diseases Nervous System Diseases Vascular Diseases Cardiovascular Diseases Brain Infarction Stroke |